40 results on '"Szado, Tania"'
Search Results
2. Clinical Value of Timely Targeted Therapy for Patients With Advanced Non–Small Cell Lung Cancer With Actionable Driver Oncogenes
3. MyPathway Human Epidermal Growth Factor Receptor 2 Basket Study: Pertuzumab + Trastuzumab Treatment of a Tissue-Agnostic Cohort of Patients With Human Epidermal Growth Factor Receptor 2–Altered Advanced Solid Tumors
4. Improving biomarker testing in advanced non-small-cell lung cancer and metastatic colorectal cancer: experience from a large community oncology network in the USA
5. Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
6. Abstract 2267: Biomarker testing and treatment (tx) patterns in a large community oncology network
7. Abstract CT032: Activity and safety of alectinib for ALK-altered solid tumors from MyPathway
8. Abstract CT128: A study evaluating targeted therapies in participants who have advanced solid tumors with genomic alterations or protein expression patterns predictive of response (MyTACTIC)
9. Evolution of biomarker testing in advanced non-small cell lung cancer (aNSCLC) and metastatic breast cancer (mBC) in U.S. community practices.
10. Phosphorylation of Inositol 1,4,5-Trisphosphate Receptors by Protein Kinase B/Akt Inhibits Ca²⁺ Release and Apoptosis
11. Biomarker testing patterns and actionability in advanced non-small cell lung cancer (aNSCLC) at OneOncology (OneOnc).
12. NGS testing patterns in advanced non-small cell lung cancer (aNSCLC) and metastatic breast cancer (mBC): OneOncology (OO) sites compared to Flatiron Health Nationwide (NAT).
13. A study evaluating targeted therapies in participants who have advanced solid tumors with genomic alterations or protein expression patterns predictive of response (MyTACTIC).
14. Sequential opening of I[P.sub.3]-sensitive [Ca.sup.2+] channels and SOC during [alpha]-adrenergic activation of rabbit vena cava
15. Endothelin-1-Mediated Wave-Like [Ca2+]i Oscillations in Intact Rabbit Inferior Vena Cava
16. Basal calcium entry in vascular smooth muscle
17. Augmented Contractile Response of Vascular Smooth Muscle in a Diabetic Mouse Model
18. Additional file 2: of Biomarker analysis of the NeoSphere study: pertuzumab, trastuzumab, and docetaxel versus trastuzumab plus docetaxel, pertuzumab plus trastuzumab, or pertuzumab plus docetaxel for the neoadjuvant treatment of HER2-positive breast cancer
19. Additional file 1: Table S1. of Biomarker analysis of the NeoSphere study: pertuzumab, trastuzumab, and docetaxel versus trastuzumab plus docetaxel, pertuzumab plus trastuzumab, or pertuzumab plus docetaxel for the neoadjuvant treatment of HER2-positive breast cancer
20. Role of sarcoplasmic reticulum in regulation of tonic contraction of rabbit basilar artery
21. Biomarker analysis of the NeoSphere study: pertuzumab, trastuzumab, and docetaxel versus trastuzumab plus docetaxel, pertuzumab plus trastuzumab, or pertuzumab plus docetaxel for the neoadjuvant treatment of HER2-positive breast cancer
22. Abstract OT3-1-01: A two-cohort, phase II, cardiac safety study of pertuzumab, trastuzumab, and neoadjuvant anthracycline-based chemotherapy in patients with HER2-positive, locally advanced, inflammatory, or early breast cancer
23. Clinical value of timely targeted therapy (TT) for patients with advanced non-small cell lung cancer (aNSCLC) with actionable driver oncogenes (ADO).
24. Role of sarcoplasmic reticulum and mitochondria in Ca2+ signaling in vascular smooth muscle
25. Pertuzumab Pharmacokinetics and Safety in Combination with Trastuzumab and Chemotherapy in Patients with Her2-Positive Advanced Gastric Cancer (Agc)
26. Pertuzumab, Trastuzumab and Chemotherapy in Her2-Positive Metastatic Gastric or Gastro-Oesophageal Junction Cancer: an International Phase III Study (Jacob)
27. MotHER: A registry for women with breast cancer who received trastuzumab (T) with or without pertuzumab (P) during pregnancy or within 6 months prior to conception.
28. Pertuzumab Monotherapy After Trastuzumab-Based Treatment and Subsequent Reintroduction of Trastuzumab: Activity and Tolerability in Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
29. Phosphorylation of inositol 1,4,5-trisphosphate receptors by protein kinase B/Akt inhibits Ca 2+ release and apoptosis
30. Emerging therapeutic targets in chronic heart failure: Part II
31. Agonist‐induced mitochondrial Ca2+transients in smooth muscle
32. Emerging therapeutic targets in chronic heart failure: Part I
33. Sequential opening of IP3-sensitive Ca2+channels and SOC during α-adrenergic activation of rabbit vena cava
34. P-0111 - Pertuzumab, Trastuzumab and Chemotherapy in Her2-Positive Metastatic Gastric or Gastro-Oesophageal Junction Cancer: an International Phase III Study (Jacob)
35. O-0021 - Pertuzumab Pharmacokinetics and Safety in Combination with Trastuzumab and Chemotherapy in Patients with Her2-Positive Advanced Gastric Cancer (Agc)
36. Phosphorylation of inositol 1,4,5-trisphosphate receptors by protein kinase B/Akt inhibits Ca2+ release and apoptosis.
37. Endothelin-1-Mediated Wave-Like [Ca]i Oscillations in Intact Rabbit Inferior Vena Cava.
38. Agonist‐induced mitochondrial Ca2+ transients in smooth muscle.
39. Sequential opening of IP3-sensitive Ca2+ channels and SOC during α-adrenergic activation of rabbit vena cava.
40. Agonist-induced mitochondrial Ca2+ transients in smooth muscle.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.